PDP1 and pulmonary arterial hypertension: Dichloroacetate reduces phosphorylation of PDH and improves GO in PAH PASMC in vitro (McMurtry et al., 2004), in rats with experimental PAH (Michelakis et al., 2002a) and PAH patients (Michelakis et al., 2017).